Cardiac amyloidosis is a progressive disease caused by the extracellular deposition of amyloid fibrils in the heart. More frequent than previously believed, it contributes to many common clinical ...
Discover the results from ASPIRED, DANISH-CRT, SyncAV PMT, Syncope-Stopper and HIS Alternative II, presented on Monday, 31 August 2026. To start, Professor Matthew Reed (The Usher Institute - ...
Yesterday, Task Force Chairs, Associate Professor Kevin Damman (University Medical Centre Groningen - Netherlands) and Professor William Herrington (University of Oxford - UK) presented the first ESC ...
Yesterday, major changes in the classification, nomenclature and treatment of heart failure (HF) in the new ESC Guidelines[1] were discussed by Task Force Chairs, Associate Professor Marianna Adamo ...
The application of guidelines improves the quality of clinical practice, therefore it is of great importance that recommendations are presented in formats that can be easily used and interpreted.
+ 2026-08-28T08:00 2026-08-28T08:00 Europe/Paris 2026 ESC Guidelines for the management of heart failure Add to calendar 2026-08-28T08:00 2026-08-28T08:00 Europe/Paris 2026 ESC Guidelines for the ...
Dyslipidaemia in CKD Antithrombotic therapy in CKD without symptomatic atherosclerotic cardiovascular disease Specific pharmacological interventions to reduce cardiovascular and/or kidney failure risk ...
Home Guidelines ESC Clinical Practice Guidelines All ESC Clinical Practice Guidelines 2026 CVD and CKD ...
The purpose of this document is to provide comprehensive guidance on the indications for CR and the management of patients in ...
Eplontersen trial did not meet its primary endpoint in transthyretin-mediated amyloid cardiomyopathy
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, fatal disease characterised by deposition of the misfolded protein transthyretin as amyloid fibrils in the heart muscle. The ...
Assess individual cardiovascular risk for different patient populations. Developed by the European Association of Preventive Cardiology, the ESC CVD Risk Calculation App provides guidance on which is ...
The European Society of Cardiology (ESC) will hold the world’s foremost cardiology meeting in Munich from 28–31 August. 12 Hot Line sessions will showcase eagerly awaited results from an unprecedented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results